期刊文献+

芒果源高降胆固醇乳酸菌的特性及其作用机制 被引量:5

Characterization and Mechanism of Lactic Acid Bacteria Isolated from Mango,with Cholesterol-Lowering Effects
原文传递
导出
摘要 目的:明确芒果源高降胆固醇乳酸菌去除胆固醇的机制,为以后应用于果汁发酵生产具有降胆固醇作用的果汁饮品提供优良的菌种。方法:对降胆固醇能力强的15个菌株进行体外耐受性及其降胆固醇吸附作用的研究,采用气-质联用色谱对体外耐受性好,降胆固醇能力高的菌株MPL1进行细胞脂肪酸组成研究。结果:12个菌株可耐受p H 1.0的极酸性环境,15个菌株在质量浓度0.3 g/100 m L的各种胆盐介质中生长良好;7个菌株在人工肠液中培养4 h后,存活率均在97%以上。菌株MPL1、MPL2、MPL5、MPL8和MPL16的生长菌体对胆固醇的去除量比休眠菌体和热灭活菌体多。菌株MPL1在胆固醇存在或没有胆固醇的培养基中生长,其细胞脂肪酸组成含量发生了变化,说明培养基中的胆固醇被菌株同化到细胞膜中。结论:15个高胆固醇降解乳酸菌中,有7个菌株可以体外高度耐酸、耐胆盐,能顺利通过胃部进入肠道环境并在肠道里良好生长。菌株MPL1通过同化和吸附胆固醇来去除胆固醇。 Objective: To understand the cholesterol removal mechanism of lactic acid bacteria isolated from mango,with cholesterol-lowering effects; to provide admirable lactic acid bacteria starters for fermentation of mango juice to obtain a kind of mango beverage with cholesterol-lowering effects. Methods: Fifteen strains with high removal rate of cholesterol were studied for their tolerance in vitro and cholesterol assimilation was determined. The cellular fatty acidscomposition of the strain MPL1 with high cholesterol-lowering effect and good tolerance was tested using GC-MS. Results: all 15 strains had tolerance characteristics against 0.3 g/100 m L bile salt, but only 12 strains could grow in the media with very low p H 1.0. The survival rate of 7 isolates was above 97% after incubation in artificial intestinal fluid.The cholesterol removal content of the growing cells of strains of MPL1, MPL2, MPL5, MPL8 and MPL16 was higher than that of the dead and resting cells of strains of MPL1, MPL2, MPL5, MPL8 and MPL16. Fatty acid composition of MPL1 showed changes in lipid profiles in cells grown in the presence of cholesterol compared with those grown without cholesterol. Fatty acid profiles suggested that cholesterol from the medium was incorporated into the cellular membrane.Conclusions: Among 15 strains with cholesterol-lowering effects, 7 strains could tolerate acid and bite salt, and they could survival in artificial gastric fluid and intestinal fluid. The strain MPL1 removed cholesterol through assimilation and absorption cholesterol.
出处 《中国食品学报》 EI CAS CSCD 北大核心 2016年第5期10-18,共9页 Journal of Chinese Institute Of Food Science and Technology
基金 国家自然科学基金项目(31272217) 广东省自然科学基金项目(2015A030313425 2015A030310225) 广东省科技计划项目(2015A02 0209121)
关键词 乳酸菌 酸耐受性 胆盐耐受性 胆固醇吸附作用 脂肪酸组成 lactic acid bacteria acid tolerance bile salt tolerance cholesterol assimilation fatty acid composition
  • 相关文献

参考文献28

  • 1Lee CMY, Barzi F, Woodwar DM, et al. Adult height and the risks of cardiovascular disease and major causes of death in the Asia-Pacific region: 21 000 deaths in 510 000 men and women[J]. Int J Epidemiol, 2009, 38: 1060-1071.
  • 2Brown MS, Goldstein JL. How LDL receptors influence cholesterol and atherosclerosis[J]. Scientific American, 1984, 251, 52-60.
  • 3Khedkar CD, Mantri JM, Garge RD, et al. Hypocholesterolemic effect of fermented milks: A review[J]. Cultured Dairy Products Journal, 1993,28: 15-18.
  • 4Manson JE, HTosteson, P MRidker, et al. The primary prevention of myocardial infarction[J]. N. Engl. J. Med., 1992, 326: 1406-1416.
  • 5Temel RE, W Tang, Y Ma, et al. Hepatic Niemann-Pick C l-like 1 regulates biliary cholesterol concentra-tions and is a target of ezetimibe[J]. J. Clin. Invest., 2007, 117: 1968-1978.
  • 6Temel RE, JK Sawyer, L Yu, et al. Biliary sterol secretion is not required for macrophage reverse cholesterol transport[J]. Cell Metab., 2010, 12: 96-102.
  • 7Greenwald CG. Overview of fat and cholesterol reduction technologies[M]// Fat and Cholesterol Reduced Foods. CHaberstroh, CEMorris, ed. London: Gulf Publishing, 1991: 21-34.
  • 8Fuller R. Probiotics: The scientific basis[M]. London: Chapman and Hall, 1992: 36-45.
  • 9Chandan RC. Enhancing market value of milk by adding cultures[J]. J. Dairy Sci., 1999, 82: 2245-2256.
  • 10de Roos NM, MB Katan. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: A review or papers published between 1988 and 1998[J]. Am. J. Clin. Nutr., 2000, 71: 405-411.

二级参考文献8

  • 1中华人民共和国卫生部.中华人民共和国药典[S].广州:广东科技出版社,1995.附录64.
  • 2PETER H,POUWEL,ROB J,et al.The potential of Lactobacillus as a carrier for oral immunization:development and preliminary characterization of vector systems for targeted delivery of antigen[J].Biotechnology,1996,(44):183-192.
  • 3NOUAILLE S,RIBEIRO L A,MIYOSHI A,et al.Heterologous protein production and delivery systems for Lactococcus lactis[J].Genet Mol Res,2003,2(1):102-111.
  • 4GRANGETTE C,MiiLLER-ALOUF H,HOLS P,et al.Enhanced mucosal delivery of antigen with cell wall mutants of Lactic acid bacteria[J].Infect Immun,2004,72(5):2731-2737.
  • 5LORENZ SCHEPPLER,MONIQUE VOGEL,ADRIAN W,et al.Recombinant Lactobacillus johnsonii as a mucosal vaccine delivery vehicle[J].Vaccine,2002,2913-2920.
  • 6HUNGER W,PEITERSEN N.New technical aspects of the preparation of starter cultures[S].Bulletin of the IDF277,1992:17-21.
  • 7赵瑞香,李元瑞,赵瑞香,孙俊良,郭洋.嗜酸乳杆菌在模拟胃肠环境中抗性的研究[J].微生物学通报,2002,29(2):35-38. 被引量:79
  • 8张扬,袁杰利.模拟消化环境对益生菌制剂的影响[J].中国微生态学杂志,2003,15(5):253-255. 被引量:20

共引文献23

同被引文献66

引证文献5

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部